01/13/2025 6:03 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 3:38 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 2:18 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 3:51 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2024 3:55 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 2:23 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024 3:26 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 3:15 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 3:19 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 2:49 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 2:54 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for MRNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter.
|
11/29/2024 2:35 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 5:33 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/08/2024 3:19 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 7:49 AM | Hussain Abbas (Reporting) Moderna (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2024 7:52 AM | Hussain Abbas (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 6:03 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 5:03 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 3:15 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 2:29 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 4:42 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 3:26 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 2:42 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:34 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 3:37 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:45 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 3:30 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 3:33 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 3:02 PM | Moderna (Issuer) Rubenstein David M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 5:31 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:19 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024 6:05 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:23 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 10:44 AM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 3:19 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:34 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 2:28 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
06/28/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:19 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:28 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 11:45 AM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:20 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 6:01 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:41 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 4:26 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 2:16 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 3:22 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024 4:27 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 4:20 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 2:36 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 2:20 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 2:11 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:36 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:34 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 3:12 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 2:12 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 2:14 PM | Garay Arpa (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 2:20 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 2:22 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 2:21 PM | Mock James M (Reporting) Mock James M (Reporting) Moderna (Subject) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 2:21 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 3:27 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 3:23 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 12:41 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024 3:03 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 3:43 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 3:24 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 3:51 PM | LANGER ROBERT (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:54 PM | Horning Sandra (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:57 PM | Moderna (Issuer) Tallett Elizabeth E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:59 PM | Moderna (Issuer) SAGAN PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 4:02 PM | Moderna (Issuer) Nader Francois (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:42 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 5:31 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 3:21 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:17 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024 3:23 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
How This Indicator Nailed Nvidia’s Last Two Rallies Perfectly (Ad) I’m not one to make super bold statements…
But today, I’m making an exception.
Because I’m 100% convinced this is the best indicator I’ve used for trading Nvidia…
Don’t believe me? Just take a look at the last two rallies:
This powerful indicator caught both moves almost perfectly. Don’t miss out—this could be the next big move. |
04/15/2024 9:58 AM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:22 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 1:03 PM | Moderna (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/09/2024 3:09 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 2:32 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 3:20 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |